EVV-12877-53120
1 vaccination
4 coded responses
6 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 423 / KY
- Registered
- 2021-08-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-02
Registered in v-safe
-
2021-08-02
Dose 1 — Pfizer-BioNTech
-
2021-08-03
Survey response — days 1–6 daily, dose 1MedDRA: Confusional state, Daydreaming, Disorientation — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Confused, absent-minded, and disorientedMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Survey response — days 1–6 daily, dose 1MedDRA: Brain fog, Confusional state, Disorientation — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Still experiencing a "foggy brain" and feel a little disoriented. In the first half of the day, I'm encountering brief episodes of confusion every 2 or so hours that last anywhere from 5 minutes to 15 minutes and become more frequent after lunch.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-06
Survey response — days 1–6 daily, dose 1MedDRA: Confusional state, Daydreaming, Memory impairment — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Still having episodes of forgetfulness, confusion, and absent-minded ness.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-09
Survey response — day 7, dose 1MedDRA: Confusional state, Daydreaming, Memory impairment — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Though not as frequent, I'm still experiencing episodes of confusion, forgetfulness, and absent-mindedness.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-18
- 2021-08-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-02 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Confused, absent-minded, and disoriented
Systemic reaction (other): Still experiencing a "foggy brain" and feel a little disoriented. In the first half of the day, I'm encountering brief episodes of confusion every 2 or so hours that last anywhere from 5 minutes to 15 minutes and become more frequent after lunch.
Systemic reaction (other): Still having episodes of forgetfulness, confusion, and absent-minded ness.
Release 9 — day 7, dose 1
Systemic reaction (other): Though not as frequent, I'm still experiencing episodes of confusion, forgetfulness, and absent-mindedness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Brain fog | ✓ | · | ✓ |
| SRO | Confusional state | ✓ | · | ✓ |
| SRO | Daydreaming | ✓ | · | ✓ |
| SRO | Disorientation | ✓ | · | ✓ |
| SRO | Memory impairment | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release